Indapamide/amlodipineAlternative Names: Amlodipine/indapamide; Natrilam
Latest Information Update: 22 Apr 2015
At a glance
- Originator Serdia Pharmaceuticals
- Class Antihypertensives; Dihydropyridines; Indoles; Small molecules; Sulfonamides
- Mechanism of Action Calcium channel antagonists; Thiazide-like diuretics
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypertension
Most Recent Events
- 25 Dec 2010 Serdia Pharmaceuticals completes a phase III trial in Hypertension in India